Singapore - English - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - aminoacetic acid (glycine); l-alanine; l-arginine; l-histidine; l-isoleucine; l-leucine; l-lysine hcl eqv l-lysine; l-methionine; l-phenylalanine; l-proline; l-serine; l-threonine; l-tryptophan; l-tyrosine; l-valine - injection - 10.30 g/l - aminoacetic acid (glycine) 10.30 g/l; l-alanine 20.70 g/l; l-arginine 11.50 g/l; l-histidine 4.80 g/l; l-isoleucine 6.00 g/l; l-leucine 7.30 g/l; l-lysine hcl eqv l-lysine 5.80 g/l; l-methionine 4.00 g/l; l-phenylalanine 5.60 g/l; l-proline 6.80 g/l; l-serine 5.00 g/l; l-threonine 4.20 g/l; l-tryptophan 1.80 g/l; l-tyrosine 0.40 g/l; l-valine 5.80 g/l

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - acetic acid 250 mg in 100 ml - 0.25% acetic acid irrigation, usp, is indicated as a constant or intermittent bladder rinse to help prevent the growth and proliferation of susceptible urinary pathogens (especially ammonia forming bacteria) in the management of patients who require prolonged placement of an indwelling urethral catheter. it also may be used for periodic irrigation of an indwelling catheter to help maintain patency by reducing the formation of calcium encrustations. none known

United States - English - NLM (National Library of Medicine)

hospira, inc. - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - acetic acid 250 mg in 100 ml - 0.25% acetic acid irrigation, usp is indicated as a constant or intermittent bladder rinse to help prevent the growth and proliferation of susceptible urinary pathogens (especially ammonia-forming bacteria) in the management of patients who require prolonged placement of an indwelling urethral catheter. it also may be used for periodic irrigation of an indwelling catheter to help maintain patency by reducing the formation of calcium encrustations. not for injection by usual parenteral routes. this solution is contraindicated for irrigation during transurethral surgical procedures.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - acetic acid 0.25 g in 100 ml - 0.25% acetic acid irrigation usp is indicated as a constant or intermittent bladder rinse to help prevent the growth and proliferation of susceptible urinary pathogens (especially ammonia-forming bacteria) in the management of patients who require prolonged placement of an indwelling urethral catheter. it also may be used for periodic irrigation of an indwelling catheter to help maintain patency by reducing the formation of calcium encrustations. 0.25% acetic acid irrigation usp is not for injection. this solution is contraindicated for irrigation during transurethral surgical procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - leucine, quantity: 4.02 g/l; phenylalanine, quantity: 3.08 g/l; methionine, quantity: 2.2 g/l; lysine hydrochloride, quantity: 3.99 g/l (equivalent: lysine, qty 3.19 g/l); isoleucine, quantity: 3.3 g/l; valine, quantity: 3.19 g/l; histidine, quantity: 2.64 g/l; threonine, quantity: 2.31 g/l; tryptophan, quantity: 990 mg/l; alanine, quantity: 11.4 g/l; glycine, quantity: 5.66 g/l; arginine, quantity: 6.32 g/l; proline, quantity: 3.74 g/l; tyrosine, quantity: 220 mg/l; serine, quantity: 2.75 g/l; sodium aceta - injection, intravenous infusion - excipient ingredients: sodium metabisulfite; glacial acetic acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - leucine, quantity: 7.3 g/l; phenylalanine, quantity: 5.6 g/l; methionine, quantity: 4 g/l; lysine hydrochloride, quantity: 7.24 g/l (equivalent: lysine, qty 5.8 g/l); isoleucine, quantity: 6 g/l; valine, quantity: 5.8 g/l; histidine, quantity: 4.8 g/l; threonine, quantity: 4.2 g/l; tryptophan, quantity: 1.8 g/l; alanine, quantity: 20.7 g/l; glycine, quantity: 10.3 g/l; arginine, quantity: 11.5 g/l; proline, quantity: 6.8 g/l; tyrosine, quantity: 400 mg/l; serine, quantity: 5 g/l; sodium acetate, quantity: 6 - injection, intravenous infusion - excipient ingredients: sodium metabisulfite; acetic acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - leucine, quantity: 7.3 g/l; phenylalanine, quantity: 5.6 g/l; methionine, quantity: 4 g/l; lysine hydrochloride, quantity: 7.24 g/l (equivalent: lysine, qty 5.8 g/l); isoleucine, quantity: 6 g/l; valine, quantity: 5.8 g/l; histidine, quantity: 4.8 g/l; threonine, quantity: 4.2 g/l; tryptophan, quantity: 1.8 g/l; alanine, quantity: 20.7 g/l; glycine, quantity: 10.3 g/l; arginine, quantity: 11.5 g/l; proline, quantity: 6.8 g/l; tyrosine, quantity: 400 mg/l; serine, quantity: 5 g/l - injection, intravenous infusion - excipient ingredients: sodium metabisulfite; glacial acetic acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Malta - English - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, dihydrate, phenylalanine, potassium chloride, histidine, arginine, aspartic acid, olive oil, threonine, tyrosine, valine, glucose monohydrate, glutamic acid, glycine, methionine, isoleucine, tryptophan, lysine, magnesium chloride, hexahydrate, serine, proline, sodium acetate, trihydrate, sodium glycerophosphate, soybean oil - emulsion for infusion - calcium chloride dihydrate phenylalanine potassium chloride histidine arginine aspartic acid olive oil threonine tyrosine valine glucose monohydrate glutamic acid glycine methionine isoleucine l-tryptophan lysine magnesium chloride hexahydrate serine proline sodium acetate trihydrate sodium glycerophosphate soybean oil - blood substitutes and perfusion solutions

United States - English - NLM (National Library of Medicine)

a-s medication solutions - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - acetic acid 20.65 mg in 1 ml - for the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial. hypersensitivity to acetic acid or any of the ingredients. perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal. safety and effectiveness in pediatric patients below the age of 3 years have not been established.

United States - English - NLM (National Library of Medicine)

unit dose services - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - acetic acid 20 mg in 1 ml - for the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial. hypersensitivity to acetic acid otic solution or any of the ingredients. perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.